Last reviewed · How we verify
LIVERPEARLS-Irinotecan
At a glance
| Generic name | LIVERPEARLS-Irinotecan |
|---|---|
| Also known as | Chemoembolization of Irinotecan in hydrogel microspheres |
| Sponsor | Grupo Espanol Multidisciplinario del Cancer Digestivo |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LIVERPEARLS-Irinotecan CI brief — competitive landscape report
- LIVERPEARLS-Irinotecan updates RSS · CI watch RSS
- Grupo Espanol Multidisciplinario del Cancer Digestivo portfolio CI